Despite nearly 97% complete vaccination coverage of the population over the age of 18, the city of Ruili in Yunnan Province, China, has recently experienced another outbreak of a new indigenous crown, highly homologous to the Delta variant of the virus. This small city on the border with Myanmar is now under a high degree of containment again. According to CNBC, the infection rate remains high in the six countries with the highest vaccination rates, five of which use the Chinese vaccine.
The Central News Agency quoted Dehong Prefecture, where Ruili is located, as informing on July 5 that as of July 4, the state has accumulated 1.7 million 2856 doses of COVID-19 vaccine and has completed the full (complete) vaccination of 934,071 people.
The briefing said that the completion rate of full vaccination for the vaccineable population (18 years old and above suitable for vaccination) in Dehong Prefecture reached 96.92%, ranking first in Yunnan Province.
According to China’s seventh census, as of Nov. 1, 2020, the resident population of Dehong Prefecture was 1,135,709, and the universal vaccination rate had also exceeded 70 percent, but it was still difficult to defeat the invasion of the Delta variant of the virus.
The 4th wave of local outbreak broke out in Ruili on the 4th, and as of the 7th, a total of 23 cases were confirmed, with one case of asymptomatic infection. Local officials pointed out that after testing seven positive samples, the virus genome sequence and Delta variant virus highly homologous.
Ruili main city on the 7th closed management, all citizens home isolation, which is located at the border crossing of the Sister Gong State Gate community was adjusted to high-risk areas.
According to the Central News Agency, according to an analysis by CNBC, most of the countries with high vaccination rates and new coronavirus infection rates worldwide are vaccinated with the Chinese vaccine.
CNBC cited data from the website Our World In Data, which identified 36 countries with more than 1,000 new cases per million people per week as of July 6, and identified countries in which more than 60 percent of the population had received at least one dose of the vaccine. The World in Data sources include the World Health Organization, national governments and researchers at Oxford University.
Of the six countries, five have national vaccination programs that use a large proportion of vaccines from China, including the United Arab Emirates, Seychelles, Mongolia, Uruguay and Chile, and the United Kingdom is the only country that does not receive the Chinese vaccine.
According to the official Mongolian News Agency, Mongolia has received 2.3 million doses of the vaccine from Sinopharm. That number is much higher than the 80,000 doses of Russia’s Satellite-V (Sputnik-V) vaccine that Mongolia had received as of last week, as well as some 255,000 doses of a vaccine developed by U.S. drugmaker Pfizer in collaboration with Germany’s BioNTech.
But epidemiologists say the best option for many countries is that they should not stop using Chinese vaccines, especially in low- and middle-income countries that do not have easy access to vaccine supplies.
But some countries are still ruling out Chinese vaccines, such as Costa Rica, which last month considered refusing to receive the Coxin vaccine.
Inactivated vaccines are easy to manufacture and safe to use, but they produce less immune antibodies than other vaccines, said Michael Head, a global health expert at the University of Southampton in the United Kingdom.
Recent Comments